section name header

Y-Site Injection Compatibility (1:1 Mixture)

Colistimethate sodium

(Mfr: APP)(Conc: 4.5 mg/mLd)

I

Isavuconazonium sulfate

(Mfr: ASP)(Conc: 1.5 mg/mLd)

Remarks:

Measured turbidity increases immediately

Ref:

3263